• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    88 Biggest Movers From Yesterday

    5/27/22 3:41:18 AM ET
    $AFRM
    $AKA
    $AMRS
    $APCX
    Finance: Consumer Services
    Finance
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AFRM alert in real time by email

    Gainers

    • Creatd, Inc. (NASDAQ:CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.
    • Apyx Medical Corporation (NASDAQ:APYX) rose 51.9% to settle at $5.62 after the company received the FDA 510(k) clearance for use of renuvion cosmetic technology in dermal resurfacing procedures.
    • Planet Green Holdings Corp. (NYSE:PLAG) gained 51.2% to close at $0.70. Planet Green recently reported a $4 million offering.
    • SciSparc Ltd. (NASDAQ:SPRC) shares surged 41.1% to close at $3.33. SciSparc reported Ethics Committee approval to conduct a Phase IIb trial in Tourette Syndrome.
    • Guardion Health Sciences, Inc. (NASDAQ:GHSI) climbed 37.5% to close at $0.2040. Guardion Health Sciences said its new Viactiv Omega Boost Gel Bites is now available for purchase on Amazon.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares jumped 37% to close at $0.87 after dipping 18% on Wednesday.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) shares climbed 31.8% to close at $0.8829 on Thursday. Healthcare Triangle recently posted a Q1 loss of $0.06 per share.
    • EBET, Inc. (NASDAQ:EBET) gained 31.3% to settle at $3.44.
    • VIQ Solutions Inc. (NASDAQ:VQS) surged 29.6% to close at $1.49.
    • OpGen, Inc. (NASDAQ:OPGN) gained 27.2% to settle at $0.4802 as the company reported publication of results from major clinical study using unyvero hospitalized pneumonia panel in The Lancet Respiratory Medicine.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) rose 25.7% to close at $8.11. Alpha Tau Medical reported R&D expenses for quarter ended march 31, 2022 of $5.2 million.
    • Quotient Limited (NASDAQ:QTNT) gained 25.6% to settle at $0.3536.
    • Baozun Inc. (NASDAQ:BZUN) climbed 25.5% to close at $9.90 after the company reported better-than-expected Q1 sales results.
    • Talkspace, Inc. (NASDAQ:TALK) gained 25.5% to settle at $1.33.
    • MOGU Inc. (NYSE:MOGU) gained 25% to close at $2.20.
    • Modine Manufacturing Company (NYSE:MOD) shares climbed 24.7% to settle at $10.85 as the company reported fourth-quarter FY22 sales growth of 12% year-on-year, to $574.4 million, beating the consensus of $538.02 million.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) jumped 24% to close at $2.07. GeoVax Labs recently announced a registered direct offering and a private placement at $1.65 per share and issued unregistered preferred investment options for a combined total of roughly $20 million.
    • Aspira Women's Health Inc. (NASDAQ:AWH) gained 23.1% to close at $0.5175. Aspira Womens Health recently posted a Q1 loss of $0.08 per share.
    • Integra Resources Corp. (NYSE:ITRG) climbed 22.3% to close at $1.15.
    • Zhihu Inc. (NYSE:ZH) rose 22.1% to close at $1.66. Zhihu reported first-quarter FY22 revenue growth of 55.4% year-on-year to $117.2 million, beating the consensus of $107.3 million.
    • Aprea Therapeutics, Inc. (NASDAQ:APRE) gained 22% to close at $0.8050.
    • Dollar Tree, Inc. (NASDAQ:DLTR) jumped 21.9% to close at $162.80 after the company reported better-than-expected Q1 results and raised FY22 guidance.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) jumped 21.7% to settle at $28.02.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) rose 21.6% to close at $0.8528.
    • Petros Pharmaceuticals recently posted a Q1 loss of $0.01 per share.
    • Eargo, Inc. (NASDAQ:EAR) gained 20.8% to close at $1.28.
    • Charah Solutions, Inc. (NYSE:CHRA) climbed 20.8% to settle at $3.14.
    • Standard BioTools Inc. (NASDAQ:LAB) rose 20.2% to close at $2.02.
    • Enochian Biosciences, Inc. (NASDAQ:ENOB) jumped 20% to settle at $4.44. Hindenburg Research recently tweeted Enochian's founder and inventor of its scientific breakthroughs has been arrested in a murder for hire plot in California.
    • Insignia Systems, Inc. (NASDAQ:ISIG) gained 19.4% to close at $9.43.
    • Macy's, Inc. (NYSE:M) climbed 19.3% to settle at $22.92 after the company reported better-than-expected Q1 EPS and sales results and raised FY22 EPS guidance above estimates.
    • Second Sight Medical Products, Inc. (NASDAQ:EYES) gained 19.1% to close at $2.12. Second Sight Medical Products Director Gregg Williams acquired a total of 222,598 shares at an average price of $1.97.
    • RumbleON, Inc. (NASDAQ:RMBL) jumped 19% to close at $16.09.
    • Endo International plc (NASDAQ:ENDP) gained 18.5% to close at $0.4709. Endo International recently initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journal reported.
    • QualTek Services Inc (NASDAQ:QTEK) rose 18.3% to close at $1.68.
    • EZFill Holdings Inc. (NASDAQ:EZFL) gained 18.3% to settle at $0.43.
    • Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) jumped 17.4% to settle at $3.65. Eledon Pharmaceuticals recently posted a Q1 loss of $0.69 per share.
    • Global Internet of People, Inc. (NASDAQ:SDH) rose 17.3% to close at $1.97.
    • Zentek Ltd. (NASDAQ:ZTEK) jumped 16.9% to settle at $2.14. The stock began trading on the Nasdaq on Tuesday following an uplisting from the OTC Pink Sheets.
    • BioLineRx Ltd. (NASDAQ:BLRX) rose 16.9% to close at $1.45.
    • a.k.a. Brands Holding Corp. (NYSE:AKA) gained 16.7% to close at $4.13.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) rose 16.3% to settle at $8.00.
    • Dutch Bros Inc. (NYSE:BROS) gained 16% to close at $35.72.
    • DXC Technology Company (NYSE:DXC) surged 16% to settle at $34.16 despite worse-than-expected Q4 results. The company also announced a contract extension for the London insurance market.
    • Profound Medical Corp. (NASDAQ:PROF) gained 15.9% to close at $9.02.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) rose 15.8% to settle at $1.3662. Helius Medical Tech recently posted a Q1 loss of $1.15 per share.
    • Genius Group Limited (NYSE:GNS) gained 15.7% to close at $7.80. Genius Group recently acquired E-Squared Education Enterprises, a South Africa-based school and vocational college.
    • VNET Group, Inc. (NASDAQ:VNET) climbed 14.9% to close at $5.40. VNET recently reported Q1 earnings results.
    • Alibaba Group Holding Limited (NYSE:BABA) rose 14.8% to settle at $94.48 after the company reported better-than-expected Q4 EPS and sales results.
    • Build-A-Bear Workshop, Inc. (NYSE:BBW) rose 14.6% to close at $19.12 after the company reported better-than-expected Q1 EPS and sales results.
    • Movado Group, Inc. (NYSE:MOV) gained 14.3% to close at $36.61 after the company reported better-than-expected Q1 results and issued FY23 guidance above estimates.
    • Dollar General Corporation (NYSE:DG) jumped 13.7% to close at $222.13 after the company reported better-than-expected Q1 EPS and sales results and reiterated FY22 EPS guidance.
    • Williams-Sonoma, Inc. (NYSE:WSM) rose 13.1% to close at $130.00 as the company reported first-quarter revenue growth of 8.1% year-over-year to $1.89 billion, beating the consensus of $1.81 billion.
    • Tupperware Brands Corporation (NYSE:TUP) jumped 12.8% to close at $6.86.
    • Vivid Seats Inc. (NASDAQ:SEAT) rose 12.6% to close at $8.88 after the company announced a $40 million share repurchase program.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) rose 12.5% to close at $0.3601. Roth Capital maintained First Wave BioPharma with a Buy and lowered the price target from $20 to $9.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) rose 12.5% to close at $2.97. Immix Biopharma recently announced positive interim data from an animal study in Soft Tissue Sarcoma (STS).
    • Trevena, Inc. (NASDAQ:TRVN) rose 12.2% to settle at $0.2475.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 11.5% to close at $7.55.
    • Groupon, Inc. (NASDAQ:GRPN) gained 10.9% to close at $15.49. Groupon’s 10% owner Pale Fire Capital Se acquired a total of 458,794 shares at an average price of $11.55.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) gained 10.7% to close at $1.0022. Benitec Biopharma posted a Q3 loss of $0.40 per share.
    • Liquidia Corporation (NASDAQ:LQDA) shares gained 10.4% to close at $4.03. Liquidia Technologies recently posted a Q1 loss of $0.30 per share.
    • iQIYI, Inc. (NASDAQ:IQ) rose 9.2% to settle at $3.91 after reporting upbeat Q1 earnings.
    • CASI Pharmaceuticals, Inc. (NASDAQ:CASI) gained 8.4% to close at $0.5203.
    • Signet Jewelers Limited (NYSE:SIG) rose 8.1% to close at $60.99.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) gained 7.6% to close at $0.3175 after jumping 118% on Wednesday. Very Good Food Company increased retail distribution across Canada with Loblaw Companies Ltd.
    • Amyris, Inc. (NASDAQ:AMRS) rose 7.1% to close at $2.27. Piper Sandler recently initiated coverage on Amyris with a Neutral rating and announced a price target of $2.5.

     

    Losers

    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) shares fell 68.3% to settle at $1.07 on Thursday after announcing new FDA request for experimental narcolepsy drug.
    • NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) shares dipped 58.2% to close at $0.5770 on Thursday as the company reported Data Safety Monitoring Board update on U.S. National Institutes of Health (NIH) study of ZYESAMI® (aviptadil) in critical COVID-19.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) dropped 36.6% to close at $3.39.
    • MSP Recovery, Inc. (NASDAQ:MSPR) fell 31.1% to close at $2.57. MSP Recovery reaffirmed its sales guidance.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) declined 27.8% to close at $1.1050.
    • Bright Green Corporation (NYSE:BGXX) fell 24.8% to close at $7.89.
    • Nutanix, Inc. (NASDAQ:NTNX) declined 23% to close at $16.50 after the company issued Q4 and FY22 sales guidance below estimates.
    • Nurix Therapeutics, Inc. (NASDAQ:NRIX) fell 22.7% to settle at $7.88 as the company reported positive dose finding data in chronic lymphocytic leukemia and advanced NX-2127 to next phase of clinical development.
    • Catalyst Biosciences, Inc. (NASDAQ:CBIO) dipped 22.4% to close at $1.11. Catalyst Biosciences recently announced it sold its complement portfolio for $60 million.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) dipped 19.8% to close at $0.1471 after the company announced a 1-for-10 reverse stock split.
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) shares fell 19.5% to close at $0.0741 after jumping 51% on Wednesday. Genocea Biosciences recently said it is winding down operations and delisting from NASDAQ.
    • Happiness Development Group Limited (NASDAQ:HAPP) shares fell 18% to close at $0.1951. Happiness Development Group shares jumped around 32% on Wednesday after the company reported a deal to sell up to 2000 electric vehicles, potentially valued at roughly $30 million.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) tumbled 17.3% to close at $0.43.
    • BIMI International Medical Inc. (NASDAQ:BIMI) fell 16.8% to close at $0.4260.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) fell 16% to close at $2.37. Vinco Ventures’ board of directors announced the delay of the distribution date for the previously announced spin-off of Cryptyde, Inc. due to contractual and regulatory conditions.
    • AppTech Payments Corp. (NASDAQ:APCX) fell 13.9% to close at $0.9990.
    • 36Kr Holdings Inc. (NASDAQ:KRKR) declined 13.5% to settle at $0.90.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) fell 12.9% to close at $3.70.
    • Viasat, Inc. (NASDAQ:VSAT) fell 11.1% to close at $36.55 following downbeat quarterly sales.
    • Q&K International Group Limited (NASDAQ:QK) dipped 8.1% to close at $0.9378.
    • The Kraft Heinz Company (NASDAQ:KHC) fell 6.1% to close at $37.07 after UBS downgraded the stock from Neutral to Sell and lowered its price target from $40 to $34.
    • Snowflake Inc. (NYSE:SNOW) fell 4.5% to close at $126.80 after the company reported financial results and issued guidance below analyst estimates.
    Get the next $AFRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFRM
    $AKA
    $AMRS
    $APCX

    CompanyDatePrice TargetRatingAnalyst
    Solana Company
    $HSDT
    4/23/2026$3.00Buy
    B. Riley Securities
    Affirm Holdings Inc.
    $AFRM
    4/22/2026$75.00Outperform
    BMO Capital Markets
    The Kraft Heinz Company
    $KHC
    4/14/2026Neutral
    BTIG Research
    Williams-Sonoma Inc.
    $WSM
    4/13/2026$218.00Neutral → Buy
    Goldman
    Nutanix Inc.
    $NTNX
    4/10/2026$44.00Overweight → Neutral
    Analyst
    Dutch Bros Inc.
    $BROS
    4/8/2026$66.00Outperform
    Telsey Advisory Group
    ViaSat Inc.
    $VSAT
    4/8/2026$49.00Underweight → Equal Weight
    Barclays
    Solana Company
    $HSDT
    4/6/2026$4.00Buy
    Maxim Group
    More analyst ratings

    $AFRM
    $AKA
    $AMRS
    $APCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lowell Matthew bought $87,616 worth of shares (40,000 units at $2.19), increasing direct ownership by 31% to 168,376 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:30:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Gunstream Stephen bought $55,801 worth of shares (26,000 units at $2.15), increasing direct ownership by 11% to 269,497 units (SEC Form 4)

    4 - Alpha Teknova, Inc. (0001850902) (Issuer)

    3/9/26 4:24:28 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $AFRM
    $AKA
    $AMRS
    $APCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman of Board Boersma Travis disposed of 33,022 units of Class B Common Stock (SEC Form 4)

    4 - Dutch Bros Inc. (0001866581) (Issuer)

    4/24/26 5:12:58 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    Large owner Dm Individual Aggregator, Llc disposed of 13,277 units of Class B Common Stock, decreasing direct ownership by 0.09% to 14,143,857 units (SEC Form 4)

    4 - Dutch Bros Inc. (0001866581) (Issuer)

    4/24/26 5:12:31 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    Large owner Dm Trust Aggregator, Llc disposed of 19,318 units of Class B Common Stock, decreasing direct ownership by 0.09% to 20,579,218 units (SEC Form 4)

    4 - Dutch Bros Inc. (0001866581) (Issuer)

    4/24/26 5:12:13 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    $AFRM
    $AKA
    $AMRS
    $APCX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Crescent Biopharma Announces Grants of Inducement Awards

    WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. ("Crescent" or the "Company") (NASDAQ:CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company's ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the "Inducement Plan"). The options were approved on April 23, 2026 and were material to each employee's acceptan

    4/24/26 4:15:00 PM ET
    $CBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    iQIYI Returns to LVL UP EXPO 2026 in Las Vegas with Blacklyte, Debuting Peter Pau AI Theater and Immersive AI Experiences

    LAS VEGAS, April 24, 2026 /PRNewswire/ -- iQIYI International showcases AI-powered storytelling, Chinese anime, and VIP giveaways at the Las Vegas Convention Center on April 24–26, 2026, in partnership with premium Canadian immersive ecosystem brand, Blacklyte. Founded in 2010, iQIYI (NASDAQ:IQ) is one of Asia's largest online entertainment platforms, and iQIYI International, launched in 2019, now serves over 100 million users across 190+ territories with a user interface and subtitles in 13 languages.Experience the Future of AI StorytellingAt this year's LVL UP EXPO, iQIYI debu

    4/24/26 8:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    VNET Publishes 2025 Environmental, Social and Governance Report

    BEIJING, April 24, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced it has published its 2025 Environmental, Social and Governance Report (the "2025 ESG Report"). This is VNET's sixth ESG report, highlighting the Company's 2025 initiatives and achievements in environmental practices, intelligent empowerment, ethical governance, and social responsibility. "ESG remains central to our approach to business innovation, contributing to our operational excellence and sustainable, high-quality growth," said Josh Sheng Chen, Founder, Executive Chairperson and Interim Chi

    4/24/26 5:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    $AFRM
    $AKA
    $AMRS
    $APCX
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Nurix Therapeutics Inc.

    SCHEDULE 13G/A - Nurix Therapeutics, Inc. (0001549595) (Subject)

    4/24/26 9:28:23 PM ET
    $NRIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Solana Company filed SEC Form 8-K: Leadership Update

    8-K - Solana Co (0001610853) (Filer)

    4/24/26 4:30:12 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form DEFA14A filed by Liquidia Corporation

    DEFA14A - Liquidia Corp (0001819576) (Filer)

    4/24/26 4:20:38 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Solana Company with a new price target

    B. Riley Securities initiated coverage of Solana Company with a rating of Buy and set a new price target of $3.00

    4/23/26 8:09:25 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    BMO Capital Markets initiated coverage on Affirm with a new price target

    BMO Capital Markets initiated coverage of Affirm with a rating of Outperform and set a new price target of $75.00

    4/22/26 7:55:46 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    BTIG Research initiated coverage on Kraft Heinz

    BTIG Research initiated coverage of Kraft Heinz with a rating of Neutral

    4/14/26 8:24:09 AM ET
    $KHC
    Packaged Foods
    Consumer Staples

    $AFRM
    $AKA
    $AMRS
    $APCX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    Leadership Updates

    Live Leadership Updates

    View All

    VNET Announces Changes to Leadership Team

    BEIJING, April 20, 2026 /PRNewswire/ -- VNET Group, Inc. (NASDAQ:VNET) ("VNET" or the "Company"), today announced that Mr. Qiyu Wang has resigned from his position as VNET's Chief Financial Officer for personal reasons, effective April 30, 2026. Mr. Wang's resignation is not due to any disagreement with the Company, nor does it relate to the Company's operations, policies, practices, accounting matters, or procedures. Mr. Josh Sheng Chen, Founder, Executive Chairperson and Interim Chief Executive Officer of VNET, commented, "On behalf of the Company, I would like to thank Qiyu for his contributions during his tenure. His financial discipline and strategic insight have been instrumental to th

    4/20/26 8:00:00 AM ET
    $VNET
    Computer Software: Programming Data Processing
    Technology

    NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company's first Chief Commercial Officer

    Mr Tyson has both clinical experience treating patients with serious mental health disorders and 25 years of successful industry commercial experience in the development and sales of medications in this fieldMr. Tyson is appointed as NRx anticipates approval of an ANDA for preservative-free ketamine and near term submission of a New Drug Application to expand ketamine labeling to encompass depression and suicidality. WILMINGTON, Del., April 13, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), a biopharmaceutical company that focuses on neuroplastic therapies for depression, PTSD, and related conditions, today announces the appointment of Glenn Tyson as the company's first

    4/13/26 7:00:00 AM ET
    $NRXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Solana Company (NASDAQ: HSDT) Appoints Madelene Gani as Chief Operating Officer and Deputy CFO to Lead Next Phase of Growth

    Gani is a proven transformation leader with track record at Hedera Hashgraph, Aptos, Gemini Space Station, and JUUL Labs. She joins to accelerate Solana Company's next phase of growth.Gani brings deep financial and operational expertise in public companies, global financial infrastructure buildout, and operational scaling that has driven hundreds of millions in value creation across hyper-growth companies.Strategic hire signals Solana Company's commitment to institutional-grade operations as it expands its digital asset treasury and infrastructure globally. NEWTOWN, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) today announced the appointment of Madelene Gani, CPA,

    4/9/26 4:15:00 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AFRM
    $AKA
    $AMRS
    $APCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by RumbleOn Inc.

    SC 13D/A - RumbleOn, Inc. (0001596961) (Subject)

    12/10/24 9:00:06 PM ET
    $RMBL
    EDP Services
    Technology

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $AFRM
    $AKA
    $AMRS
    $APCX
    Financials

    Live finance-specific insights

    View All

    Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

    CLEARWATER, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that its financial results for the first quarter of fiscal year 2026 will be released before markets open on Thursday, May 7th. Management will host a conference call at 8:00 a.m. Eastern Time on Thursday, May 7th, to discuss the results of the quarter, followed by a question-and-answer session. To listen to the call by phone, interested parties may dial 800-717-1738 (or 646-307-1865 for international callers) and provide access code 81537.

    4/23/26 8:00:00 AM ET
    $APYX
    Medical/Dental Instruments
    Health Care

    Groupon Announces Date for First Quarter 2026 Financial Results

    Chicago, Illinois--(Newsfile Corp. - April 23, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Friday, May 8, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NASDAQ:GRPN) is a trusted loc

    4/23/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    iQIYI to Report First Quarter 2026 Financial Results on May 18, 2026

    BEIJING, April 23, 2026 (GLOBE NEWSWIRE) -- iQIYI, Inc. (NASDAQ:IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced that it will report its financial results for the first quarter ended March 31, 2026 before the U.S. market opens on May 18, 2026. iQIYI's management will hold an earnings conference call at 7:00 AM on May 18, 2026, U.S. Eastern Time (7:00 PM on May 18, 2026, Beijing Time). Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique access PIN by a calendar invite. Participant Online Registration: https

    4/23/26 5:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary